Oligodendrocytes are targets of HIV-1 tat: NMDA and AMPA receptor-mediated effects on survival and development

Abstract

Myelin pallor in HIV+ individuals can occur very early during the disease process. While myelin damage might partly originate from HIV-induced vascular changes, the timing suggests that myelin and/or oligodendrocytes (OLs) may be directly affected. Histological (Golgi–Kopsch, electron microscopy) and biochemical studies have revealed an increased occurrence of abnormal OL/myelin morphology and dysregulated myelin protein expression in transgenic mice expressing the HIV-1 transactivator of transcription (Tat) protein. This suggests that viral proteins by themselves might cause OL injury. Since Tat interacts with NMDARs, we hypothesized that activation of NMDARs and subsequent disruption of cytoplasmic Ca2+ ([Ca2+]i) homeostasis might be one cause of white matter injury after HIV infection. In culture, HIV-1 Tat caused concentration-dependent death of immature OLs, while more mature OLs remained alive but had reduced myelin-like membranes. Tat also induced [Ca2+]i increases and Thr-287 autophosphorylation of Ca2+/calmodulin-dependent protein kinase II+ (CaMKII2+) in OLs. Tat-induced [Ca2+]i was attenuated by the NMDAR antagonist MK801, and also by the AMPA/ kainate receptor antagonist CNQX. Importantly, both MK801 and CNQX blocked Tat-induced death of immature OLs, but only MK801 reversed Tat effects on myelin-like membranes. These results suggest that OLs can be direct targets ofHIVproteins released from infected cells. Although viability and membrane production are both affected by glutamatergic receptor-mediated Ca2+ influx, and possibly the ensuing CaMKII2+ activation, the roles of AMPARs and NMDARs appear to be different and dependent on the stage of OL differentiation.